Pharmacotherapy of Obesity: An Updated Overview
Obesity is an emerging epidemic in Canada that poses a threat to public health. Pharmaceutical weight management is an option for managing excess weight. In this review, we briefly discuss the pathophysiology of obesity and present the current pharmacotherapy for its treatment, focusing on orlistat, naltrexone/bupropion, liraglutide, and semaglutide. In addition, we briefly discuss upcoming pharmacotherapies for the management of obesity.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Mohamed El Hussein, Daniel Favell Tags: Featured Article Source Type: research
More News: Alli | Bupropion | Canada Health | Eating Disorders & Weight Management | Epidemics | Epidemiology | International Medicine & Public Health | Nurses | Nursing | Obesity | Victoza | Wellbutrin | Xenical